Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 81.00
+1.00 (1.25%)
Jul 15, 2026, 4:25 PM CET
Oncoinvent ASA Market Cap
Oncoinvent ASA has a market cap or net worth of 362.75 million as of July 15, 2026.
Market Cap
362.75M
Enterprise Value
188.70M
Revenue
28.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
81.00
Market Cap Chart
Since October 30, 2025, Oncoinvent ASA's market cap has increased from 186.40M to 362.75M, an increase of 94.61%. That is a compound annual growth rate of 156.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 362.75M | 64.97% |
| Dec 30, 2025 | 219.89M | 17.96% |
| Oct 30, 2025 | 186.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 1.75B |
| Thor Medical ASA | 1.50B |
| ArcticZymes Technologies ASA | 970.36M |
| Nykode Therapeutics AS | 904.53M |
| Lytix Biopharma ASA | 767.46M |
| Zelluna ASA | 579.45M |
| SoftOx Solutions AS | 244.57M |
| Arctic Bioscience AS | 87.61M |